4//SEC Filing
Parra Raul Jr. 4
Accession 0001415889-25-006304
CIK 0000856982other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:20 PM ET
Size
17.4 KB
Accession
0001415889-25-006304
Insider Transaction Report
Form 4
Parra Raul Jr.
CFO AND TREASURER
Transactions
- Award
Common Stock, No Par Value
2025-02-27+20,760→ 37,121 total - Sale
Common Stock, No Par Value
2025-02-28$98.81/sh−12,451$1,230,283→ 24,201 total - Tax Payment
Common Stock, No Par Value
2025-02-27$98.50/sh−8,309$818,437→ 28,812 total - Award
Common Stock, No Par Value
2025-02-28+7,840→ 36,652 total
Holdings
- 2,770(indirect: By 401(k))
Common Stock, No Par Value
- 9,681
Non-qualified stock options (right to buy)
Exercise: $56.25From: 2022-03-19Exp: 2028-03-19→ Common Stock (9,681 underlying) - 14,570
Non-qualified stock options (right to buy)
Exercise: $65.03From: 2023-02-28Exp: 2029-02-28→ Common Stock (14,570 underlying) - 13,576
Non-qualified stock options (right to buy)
Exercise: $70.58From: 2024-02-28Exp: 2030-02-28→ Common Stock (13,576 underlying) - 5,361
Non-qualified stock options (right to buy)
Exercise: $37.71From: 2021-02-26Exp: 2027-02-26→ Common Stock (5,361 underlying)
Footnotes (9)
- [F1]Represents plan holdings as of 02/28/2025.
- [F2]These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02.28.2022.
- [F3]The Reporting Person surrendered 8,309 shares of common stock to the Issuer for payroll taxes. No shares were sold in the open market.
- [F4]Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
- [F5]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.09 to $99.345, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F6]Becomes exercisable in equal annual installments of 25% commencing 02/26/2021.
- [F7]Becomes exercisable in equal annual installments of 25% commencing on 03/19/2022.
- [F8]Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
- [F9]Becomes exercisable in equal annual installments of 25% commencing 02/28/2024.
Documents
Issuer
MERIT MEDICAL SYSTEMS INC
CIK 0000856982
Entity typeother
Related Parties
1- filerCIK 0001742555
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:20 PM ET
- Size
- 17.4 KB